Hamza Habeeballah
Papers
1
Total Citations
4
H-Index
1
About
Hamza Habeeballah is a pioneering researcher at the intersection of neuroscience, developmental toxicology, and advanced biofabrication. His work focuses on understanding how widely prescribed neurological drugs affect early brain development, using cutting-edge 3D cell culture technologies. His most cited study, published in 2024, investigates the effects of pregabalin—a common medication for neurological disorders—on embryonic cortical neuron development. To address the inadequately explored risks of prenatal exposure, Habeeballah employed ultrashort self-assembling peptides to create sophisticated 3D neuronal cultures, combined with an in-house developed high-throughput robotic 3D bioprinting system. This innovative approach allows for more physiologically relevant models than traditional 2D cultures, enabling precise, scalable assessment of drug effects on neuronal architecture and function. With 4 citations to date, this work is gaining traction as a methodological breakthrough. Habeeballah’s contributions are notable for merging biomaterials engineering, automated fabrication, and neurodevelopmental pharmacology, offering a powerful platform for safer drug screening during pregnancy. His research holds significant promise for advancing personalized medicine and regulatory toxicology.
Research Focus
Key Achievements
Top Papers
- 1